🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

ASAS Case of the Month - March 2022 Back pain in a young patient with psoriasis - is it axial SpA or PsA? Detailed discussion in the video below. youtu.be/OgfZcAoWRf4

Great collaborative work under the guidance and drive of Hanna Johnsson 🙏👏🕺

Dr. Fabian Proft Big team effort - thanks to all contributors!

Bimekizumab (Bimzelx) has been EMA approved to treat adults with active PsA & axial spondylarthritis in the EU. This dual IL-17 A/F inhibitor is approved to treat moderate -severe plaque psoriasis in the EU, Canada, UK & Japan; but not yet in USA wb.md/43SnMSP

Our talented Y-GRAPPiAns have curated another indispensable "Do Not Miss" newsletter, spotlighting noteworthy abstracts scheduled for presentation at the upcoming 2023 ACR Congress. 👏Access it here: grappanetwork.org/wp-content/upl…

Great work by Mohamad Bittar Gizem Ayan André Ribeiro Raphael Micheroli Tuğba İzci Duran et al. 🎩🎉💡🙏

Oral ulcers by Haner Direskeneli is clear review. #ACR23 #ACRambassador

Thrilled to share our review🚨: "Treatment strategies for Spondyloarthritis: Precision Medicine or 'One Size Fits All'?" 💊💉 🎯Key takeaway: Precision medicine offers hope for tailored, effective treatment, but there’s still work to do! 🛠️ 👉sciencedirect.com/science/articl… Tuğba İzci Duran

Excelente revisión 🗂️ de tratamientos de espondiloartritis Acceso abierto 🔑 sciencedirect.com/science/articl… GRESSER CEADE Dr. Fabian Proft Tuğba İzci Duran